209 results on '"Budnik, Ivan"'
Search Results
2. Can T-cell and B-cell excision circles predict development of inhibitors in pediatric hemophilia A?
3. Management of surgery in persons with hemophilia A receiving emicizumab prophylaxis: data from a national hemophilia treatment center
4. Factor VIII inhibitors in hemophilia A treated with emicizumab: longitudinal follow-up of outcomes
5. Anti-TFPI for hemostasis induction in patients with rare bleeding disorders, an ex vivo thrombin generation (TG) guided pilot study
6. Genetic ablation of myeloid integrin α9 attenuates early atherosclerosis.
7. The potential role of emicizumab prophylaxis in severe von Willebrand disease
8. Thromboelastometry assessment of the effects of fibrinogen, activated prothrombin complex concentrate, and tranexamic acid on clot formation and fibrinolysis in a model of trauma-induced coagulopathy
9. The relationship between oxidative stress and cytogenetic abnormalities in B-cell chronic lymphocytic leukemia
10. Emicizumab prophylaxis in infants: Single‐centre experience
11. Urinary biomarkers of latent inflammation and fibrosis in children with vesicoureteral reflux
12. Immune Factors in Deep Vein Thrombosis Initiation
13. Management of surgery in hemophilia A patients on emicizumab prophylaxis: Data from a national hemophilia treatment center
14. 3K3A-Activated Protein C Inhibits Choroidal Neovascularization Growth and Leakage and Reduces NLRP3 Inflammasome, IL-1β, and Inflammatory Cell Accumulation in the Retina
15. Combination of hemostatic therapies for treatment of patients with hemophilia A and inhibitors
16. Thrombin generation as a predictor of thromboembolic events in multiple myeloma patients
17. Bleeding phenotype and hemostatic evaluation by thrombin generation in children with Noonan syndrome: A prospective study.
18. In-vitro assessment of the effects of fibrinogen, recombinant factor VIIa and factor XIII on trauma-induced coagulopathy
19. Correction: Pediatric literature trends: high-level analysis using text-mining
20. Interaction between adenosine diphosphate receptors and protein-kinase C isoforms in platelet adhesion under flow condition
21. Synergistic effect of signaling from receptors of soluble platelet agonists and outside-in signaling in formation of a stable fibrinogen-integrin αIIbβ3-actin cytoskeleton complex
22. Effects of extensive mobilization and tension anastomosis in anorectal reconstruction (experimental study)
23. 3K3A-Activated Protein C Prevents Microglia Activation, Inhibits NLRP3 Inflammasome and Limits Ocular Inflammation
24. Association between Thrombin Generation and Clinical Characteristics in COVID-19 Patients
25. Can T-cell and B-cell excision circles predict development of inhibitors in pediatric hemophilia A?
26. Application of a clinical decision rule and laboratory assays in pediatrics: Adult heparin‐induced thrombocytopenia
27. Rivaroxaban treatment among children with cancer‐associated thromboembolism: Real‐world data
28. Model of trauma-induced coagulopathy including hemodilution, fibrinolysis, acidosis, and hypothermia: Impact on blood coagulation and platelet function
29. Association between Thrombin Generation and Clinical Characteristics in COVID-19 Patients.
30. Risk assessment of simple phacoemulsification in patients on combined anticoagulant and antiplatelet therapy
31. Pediatric severe factor XI deficiency: A multicenter study
32. Real-World Data on Bleeding Patterns of Hemophilia A Patients Treated with Emicizumab
33. Urinary cytokines as markers of latent inflammation in children with chronic pyelonephritis and anorectal malformations
34. Molecular Mechanisms of Skewed X-Chromosome Inactivation in Female Hemophilia Patients—Lessons from Wide Genome Analyses
35. Real World Data of Extended Venous Thromboembolism Prophylaxis with Low Dose Apixaban Following Cancer Associated Thrombosis
36. Platelets from Ehlers-Danlos Syndrome Patients Exhibit Reduced GPVI Levels and Impaired Integrin αIIbβ3 inside-out Signaling
37. Intravenous 3K3A-Activated Protein C Inhibits Murine Ocular Inflammation and Suppresses Ocular Choroidal Neovascularization
38. Emicizumab prophylaxis: Prospective longitudinal real‐world follow‐up and monitoring
39. Pediatric literature trends: high-level analysis using text-mining
40. Activated Protein C (APC) and 3K3A-APC-Induced Regression of Choroidal Neovascularization (CNV) Is Accompanied by Vascular Endothelial Growth Factor (VEGF) Reduction
41. Emicizumab prophylaxis in haemophilia patients older than 50 years with cardiovascular risk factors: Real‐world data
42. A Single Low-Dose of Methylphenidate Improves Abnormal Visual Field Testing
43. Pediatric severe factor XI deficiency: A multicenter study.
44. The Potential Role of Emicizuamb Prophylaxis in Severe Von Willebrand Disease
45. Emicizumab treatment and monitoring in a paediatric cohort: real‐world data
46. Thromboelastometry assessment of the effects of fibrinogen, activated prothrombin complex concentrate, and tranexamic acid on clot formation and fibrinolysis in a model of trauma-induced coagulopathy
47. Urinary biomarkers of latent inflammation and fibrosis in children with vesicoureteral reflux
48. A Single Low-Dose of Methylphenidate Improves Abnormal Visual Field Testing.
49. Prospective Controlled Monitoring of Hemlibra Prophylaxis Initiation in a Large Cohort of Hemophilia a Patients- Real World Data
50. Single Low Dose of rFVIIa Combined with Antifibrinolytic Agent is a Simple and Safe Treatment for Factor XI-Deficient Patients undergoing Surgery
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.